Your Health, We Care
Dabrafenib is indicated for the treatment of patients with unresectable or metastatic melanoma 4 with BRAF V600E mutation as detected by an FDA-approved test.
Limitation of use: Dabrafenib is not indicated for treatment of patients with wild-type BRAF 6 melanoma .
from FDA,2013.05
Scan code
Whatsapp
Dabrafenib is an important therapeutic drug that plays a key role in the treatment of specific diseases. This article will detail the applicable populations for dabrafenib and its ···【more】
Article source：Lucius LaosRelease date：2025-01-10Recommended：114
Dabrafenib is a targeted therapy drug with a specific scope of application in clinical applications.What diseases is Laos Luciosdharafinil suitable forDabrafenib is mainly targeted···【more】
Article source：Lucius LaosRelease date：2025-01-10Recommended：122
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
